Michael M. Wick

2009

In 2009, Michael M. Wick earned a total compensation of $1M as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 14% decrease compared to previous year.

Compensation breakdown

Option Awards$490,078
Salary$514,000
Total$1,004,078

Wick received $514K in salary, accounting for 51% of the total pay in 2009.

Wick also received $490.1K in option awards.

Rankings

In 2009, Michael M. Wick's compensation ranked 4,451st out of 9,885 executives tracked by ExecPay. In other words, Wick earned more than 55.0% of executives.

ClassificationRankingPercentile
All
4,451
out of 9,885
55th
Division
Manufacturing
1,586
out of 3,690
57th
Major group
Chemicals And Allied Products
311
out of 871
64th
Industry group
Drugs
188
out of 643
71st
Industry
Pharmaceutical Preparations
148
out of 446
67th
Source: SEC filing on April 7, 2010.

Wick's colleagues

We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2009.

2009

Cynthia Butitta

MabVax Therapeutics Holdings

Chief Financial Officer

2009

Marc Steuer

MabVax Therapeutics Holdings

Senior Vice President, Business Development

2009

William Kaplan

MabVax Therapeutics Holdings

General Counsel

2009

Stefan Ryser

MabVax Therapeutics Holdings

Former Senior Vice President, Corporate Strategy

You may also like